162 related articles for article (PubMed ID: 25149762)
1. A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma.
Aka PV; Kemp TJ; Rabkin CS; Shiels MS; Polizzotto MN; Lauria C; Vitale F; Pinto LA; Goedert JJ
J Infect Dis; 2015 Jan; 211(2):226-9. PubMed ID: 25149762
[TBL] [Abstract][Full Text] [Related]
2. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory component of Kaposi sarcoma.
Pantanowitz L; Moses AV; Dezube BJ
Exp Mol Pathol; 2009 Oct; 87(2):163-5. PubMed ID: 19591823
[TBL] [Abstract][Full Text] [Related]
4. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma.
Pyakurel P; Massambu C; Castaños-Vélez E; Ericsson S; Kaaya E; Biberfeld P; Heiden T
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):678-83. PubMed ID: 15167286
[TBL] [Abstract][Full Text] [Related]
6. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive Kaposi's Sarcoma in an Iraqi boy received Valproic acid: a case report and review of literature.
Al-Kzayer LF; Keizer P; Abdulraheem FT; Sano K; Kamata M; Sakashita K; Habbaba LA; Koike K
BMC Pediatr; 2016 Jul; 16():111. PubMed ID: 27459853
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
9. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents.
Ensoli B; Stürzl M
Cytokine Growth Factor Rev; 1998 Mar; 9(1):63-83. PubMed ID: 9720757
[TBL] [Abstract][Full Text] [Related]
11. Pyogenic granuloma-like Kaposi sarcoma: a diagnostic pitfall.
Scott PL; Motaparthi K; Krishnan B; Hsu S
Dermatol Online J; 2012 Mar; 18(3):4. PubMed ID: 22483515
[TBL] [Abstract][Full Text] [Related]
12. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for classical Kaposi's sarcoma.
Goedert JJ; Vitale F; Lauria C; Serraino D; Tamburini M; Montella M; Messina A; Brown EE; Rezza G; Gafà L; Romano N;
J Natl Cancer Inst; 2002 Nov; 94(22):1712-8. PubMed ID: 12441327
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology.
Ensoli B; Sirianni MC
Crit Rev Oncog; 1998; 9(2):107-24. PubMed ID: 9973245
[TBL] [Abstract][Full Text] [Related]
15. Disseminated Kaposi sarcoma in a HIV negative patient.
Lin G; Wang H; Fan X; Li H; Wang Z; Lin D; Yang S; Zhang X
Int J Clin Exp Pathol; 2015; 8(3):3378-80. PubMed ID: 26045873
[TBL] [Abstract][Full Text] [Related]
16. Lymphangioma-like Kaposi sarcoma: case report.
Posada García C; García-Cruz A; García-Doval I; De La Torre C; Cruces MJ
Dermatol Online J; 2009 Sep; 15(9):13. PubMed ID: 19931000
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
18. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma.
Lambert M; Gannagé M; Karras A; Abel M; Legendre C; Kerob D; Agbalika F; Girard PM; Lebbe C; Caillat-Zucman S
Blood; 2006 Dec; 108(12):3871-80. PubMed ID: 16926293
[TBL] [Abstract][Full Text] [Related]
19. Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8.
Jackson CC; Dickson MA; Sadjadi M; Gessain A; Abel L; Jouanguy E; Casanova JL
Pediatr Blood Cancer; 2016 Mar; 63(3):392-7. PubMed ID: 26469702
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of endothelial markers and HHV-8 staining in gastrointestinal Kaposi sarcoma and its difference in endoscopic tumor staging.
Nagata N; Igari T; Shimbo T; Sekine K; Akiyama J; Hamada Y; Yazaki H; Ohmagari N; Teruya K; Oka S; Uemura N
World J Gastroenterol; 2013 Jun; 19(23):3608-14. PubMed ID: 23801862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
